<DOC>
	<DOCNO>NCT02710409</DOCNO>
	<brief_summary>Influenza acute respiratory disease cause influenza virus . There three type virus include A , B C. Both type A type B viruses cause acute febrile respiratory tract infection , characterize sudden fever , headache , muscle pain , cough , sore throat , nasal congestion general malaise . The main transmission influenza highly contagious aerosol droplet contain influenza virus pass infected people susceptible population . Each year fall winter infection influenza widespread various age group , high incidence rate . Although influenza generally self-limiting disease , child , elderly ( especially 65 year old chronic heart , lung , kidney , liver , blood metabolic diseases diabetes certain disease ) poor immunity function , influenza easily lead serious flu complication pneumonia , result severe increase morbidity mortality . In order evaluate safety immunogenicity quadrivalent influenza vaccine produce Jiangsu Jindike Biotechnology Co. , Ltd. phase III clinical trial plan conduct healthy Chinese subject age 3 year old .</brief_summary>
	<brief_title>A Phase III Clinical Trial An Inactivated Quadrivalent Influenza Vaccine Healthy Subjects Aged 3 Years Older</brief_title>
	<detailed_description>Subjects randomize three arms- Experimental Group , Active Comparator A Active Comparator B ratio 2:1:1 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 3 year old Healthy subject judge medical history clinical examination Subjects guardians able understand sign inform consent Subjects guardian comply requirement protocol Subjects temperature &lt; =37.0°C axillary setting Subject medical family history following : allergic history , seizure , epilepsy , brain mental disease Any prior administration influenza vaccine last 6 month Subject allergic ingredient vaccine Female subject age ≥18 year positive result urine pregnancy test pregnancy baby nursing period Subject damage low immune function already know Subject seasonal influenza medical history last 6 month Subject acute febrile illness infectious disease Major congenital defect serious chronic illness , include perinatal brain damage Thrombocytopenia , blood coagulation disorder bleed difficulty intramuscular injection Subject serious allergic history Subject medical history suitable vaccination faint injection Any prior administration immunodepressant corticosteroid last 6 month Any prior administration blood product last 3 month Any prior administration research medicine/vaccine last 30 day Any prior administration attenuate live vaccine last 30 day Any prior administration subunit inactivate vaccine last 14 day , pneumococcal vaccine Any medical , psychological , social condition judge investigator , may interfere subject 's compliance protocol signature inform consent</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>safety , immunogenicity , quadrivalent influenza vaccine</keyword>
</DOC>